Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wiese

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Analogs of a 4-aminothieno[2,3-d]pyrimidine lead (QB13) as modulators of P-glycoprotein substrate specificityHans-Georg Häcker, Antje de la Haye, Katja Sterz, et al.
Journal of Medicinal Chemistry|August 14, 2020
Superior Pyrimidine Derivatives as Selective ABCG2 Inhibitors and Broad-Spectrum ABCB1, ABCC1, and ABCG2 AntagonistsKatja Silbermann, Jiyang Li, Vigneshwaran Namasivayam, et al.
Molecular Imaging and Biology|September 7, 2006
99mTc-Sestamibi, a sensitive probe for in vivo imaging of P-glycoprotein inhibition by modulators and mdr1 antisense oligodeoxynucleotidesVeronika Jekerle, Jing-Hung Wang, Deborah A Scollard, et al.
Journal of Agromedicine|July 14, 2016
Acute Illness Associated with Exposure to a New Soil Fumigant Containing Dimethyl Disulfide-Hillsborough County, Florida, 2014Prakash R Mulay, Philip Cavicchia, Sharon M Watkins, et al.
Journal of Medicinal Chemistry|September 23, 2017
Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y<sub>2</sub> ReceptorMuhammad Rafehi, Alexander Neumann, Younis Baqi, et al.
Muscle & Nerve|June 18, 2016
The PTPN22 gene is associated with idiopathic inflammatory myopathyAdam Maundrell, Sue Lester, Maureen Rischmueller, et al.
International Journal of Cancer|April 29, 2006
In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniquesVeronika Jekerle, Werner Klinkhammer, Deborah A Scollard, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|April 17, 2014
Differential effects of the oncogenic BRAF inhibitor PLX4032 (vemurafenib) and its progenitor PLX4720 on ABCB1 functionMartin Michaelis, Florian Rothweiler, Thomas Nerreter, et al.
BMC Research Notes|October 11, 2014
Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expressionMartin Michaelis, Florian Rothweiler, Thomas Nerreter, et al.
European Journal of Medicinal Chemistry|May 11, 2016
Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistanceVeronika F S Pape, Szilárd Tóth, András Füredi, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Analogs of a 4-aminothieno[2,3-d]pyrimidine lead (QB13) as modulators of P-glycoprotein substrate specificityHans-Georg Häcker, Antje de la Haye, Katja Sterz, et al.
Journal of Medicinal Chemistry|August 14, 2020
Superior Pyrimidine Derivatives as Selective ABCG2 Inhibitors and Broad-Spectrum ABCB1, ABCC1, and ABCG2 AntagonistsKatja Silbermann, Jiyang Li, Vigneshwaran Namasivayam, et al.
Molecular Imaging and Biology|September 7, 2006
99mTc-Sestamibi, a sensitive probe for in vivo imaging of P-glycoprotein inhibition by modulators and mdr1 antisense oligodeoxynucleotidesVeronika Jekerle, Jing-Hung Wang, Deborah A Scollard, et al.
Journal of Agromedicine|July 14, 2016
Acute Illness Associated with Exposure to a New Soil Fumigant Containing Dimethyl Disulfide-Hillsborough County, Florida, 2014Prakash R Mulay, Philip Cavicchia, Sharon M Watkins, et al.
Journal of Medicinal Chemistry|September 23, 2017
Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y<sub>2</sub> ReceptorMuhammad Rafehi, Alexander Neumann, Younis Baqi, et al.
Muscle & Nerve|June 18, 2016
The PTPN22 gene is associated with idiopathic inflammatory myopathyAdam Maundrell, Sue Lester, Maureen Rischmueller, et al.
International Journal of Cancer|April 29, 2006
In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniquesVeronika Jekerle, Werner Klinkhammer, Deborah A Scollard, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|April 17, 2014
Differential effects of the oncogenic BRAF inhibitor PLX4032 (vemurafenib) and its progenitor PLX4720 on ABCB1 functionMartin Michaelis, Florian Rothweiler, Thomas Nerreter, et al.
BMC Research Notes|October 11, 2014
Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expressionMartin Michaelis, Florian Rothweiler, Thomas Nerreter, et al.
European Journal of Medicinal Chemistry|May 11, 2016
Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistanceVeronika F S Pape, Szilárd Tóth, András Füredi, et al.
Pageof 12